top of page
gradientForSurfBreak.png

Item List

PR Newswire
Strados Labs Receives FDA 510(k) Clearance for Home Use of its Smart Sensor Platform

Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and predictions of worsening respiratory diseases, today announced it has received FDA Class II 510(k) clearance for home use of its first product, RESP®, which make this its second FDA clearance in less than 18 months.

Recent Posts

General News

Carlsmed.png

Hospitals Work Through Fallout from CrowdStrike Outage ...

Modern Healthcare

General News

Carlsmed.png

Humana Makes Investment in AI-powered Medicare Enrollment Platform Healthpilot ...

Fierce Healthcare

General News

Carlsmed.png

Healthcare Costs Set to Rise by as Much as 8% in 2025: PwC ...

Fierce Healthcare

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page